Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 9, 2023Transplantation and Cellular TherapyOpen Access

Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome

View Full Paper
Ask AI
Bookmark
Share

Authors

MHMelissa HinesSt. Jude Children's Research HospitalTKTristan KnightUniversity of Hawaiʻi at MānoaKMKevin O. McNerneyNorthwestern University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hines et al. (2023) studied this question.

synapsesocial.com/papers/6a01d5946f2c4fd2e25ca370https://doi.org/10.1016/j.jtct.2023.03.006
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1American Society for Transplantation and Cellular Therapy Series: #3—Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation2021 · 132 citations
  2. 2How I treat hemophagocytic lymphohistiocytosis in the adult patient2015 · 421 citations
  3. 3Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell–Associated Neurotoxicity Syndrome Patients with B-Cell ALL Receiving CAR T192022 · 68 citations
  4. 4Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia2015 · 1,757 citations